[{"id":"bc012686-0d60-477a-a439-6865724c6cda","acronym":"","url":"https://clinicaltrials.gov/study/NCT05187858","created_at":"2022-01-12T15:53:47.160Z","updated_at":"2024-07-02T16:35:53.080Z","phase":"Phase 1","brief_title":"A Study of LNP3794 in Subjects With NRAS/KRAS Mutated Advanced or Metastatic Refractory Solid Tumors","source_id_and_acronym":"NCT05187858","lead_sponsor":"Lupin Ltd.","biomarkers":" KRAS • NRAS","pipe":" | ","alterations":" KRAS mutation • NRAS mutation","tags":["KRAS • NRAS"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e KRAS mutation • NRAS mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e LNP3794"],"overall_status":"Completed","enrollment":" Enrollment 15","initiation":"Initiation: 09/22/2020","start_date":" 09/22/2020","primary_txt":" Primary completion: 02/23/2022","primary_completion_date":" 02/23/2022","study_txt":" Completion: 06/30/2022","study_completion_date":" 06/30/2022","last_update_posted":"2023-03-17"},{"id":"3b9afb6e-67b8-4dff-9bb1-f4af9451f29d","acronym":"","url":"https://clinicaltrials.gov/study/NCT04742556","created_at":"2021-02-08T13:52:13.055Z","updated_at":"2024-07-02T16:36:00.506Z","phase":"Phase 1","brief_title":"A Study to Test Different Doses of BI 3011441 in Japanese People With Different Types of Advanced Cancer (NRAS/KRAS Mutation Positive)","source_id_and_acronym":"NCT04742556","lead_sponsor":"Boehringer Ingelheim","biomarkers":" KRAS • NRAS","pipe":" | ","alterations":" KRAS mutation • NRAS mutation","tags":["KRAS • NRAS"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e KRAS mutation • NRAS mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e LNP3794"],"overall_status":"Completed","enrollment":" Enrollment 15","initiation":"Initiation: 03/15/2021","start_date":" 03/15/2021","primary_txt":" Primary completion: 10/13/2022","primary_completion_date":" 10/13/2022","study_txt":" Completion: 10/20/2022","study_completion_date":" 10/20/2022","last_update_posted":"2022-11-14"}]